![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/416 | |
A61K 31/4178 | |||
A61K 31/4184 | |||
A61K 31/437 | |||
A61K 31/4439 | |||
A61K 31/454 | |||
A61K 31/496 | |||
A61K 31/5377 | |||
A61K 31/541 | |||
A61K 31/551 | |||
A01N 43/52 | |||
C07D 231/56 | |||
C07D 401/12 | |||
C07D 401/14 | |||
C07D 403/04 | |||
C07D 403/12 | |||
C07D 403/14 | |||
C07D 405/12 | |||
C07D 409/12 | |||
C07D 487/04 | |||
C07D 487/08 |
(11) | Number of the document | 2987487 |
(13) | Kind of document | T |
(96) | European patent application number | 15177852.9 |
Date of filing the European patent application | 2010-08-09 | |
(97) | Date of publication of the European application | 2016-02-24 |
(45) | Date of publication and mention of the grant of the patent | 2020-10-07 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
232603 P | 2009-08-10 | US | |
305459 P | 2010-02-17 | US |
(72) |
HOOD, John, US
WALLACE, David Mark, US
KC, Sunil Kumar, US
|
(73) |
BioSplice Therapeutics, Inc. ,
9360 Towne Centre Drive, San Diego, CA 92121,
US
|
(54) | INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF |
INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF |